These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15280922)

  • 21. Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.
    Webster MR; Kamat C; Connis N; Zhao M; Weeraratna AT; Rudek MA; Hann CL; Freel Meyers CL
    Mol Cancer Ther; 2014 Feb; 13(2):297-306. PubMed ID: 24310621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
    Manzano-Moreno FJ; Ramos-Torrecillas J; De Luna-Bertos E; Ruiz C; García-Martínez O
    J Craniomaxillofac Surg; 2015 Apr; 43(3):396-401. PubMed ID: 25614214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.
    Gordon S; Helfrich MH; Sati HI; Greaves M; Ralston SH; Culligan DJ; Soutar RL; Rogers MJ
    Br J Haematol; 2002 Nov; 119(2):475-83. PubMed ID: 12406088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
    Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
    Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines.
    Alcaraz M; Olivares A; Achel DG; Alcaraz-Saura M
    Anticancer Res; 2013 Aug; 33(8):3217-24. PubMed ID: 23898082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
    Lee MV; Fong EM; Singer FR; Guenette RS
    Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.
    Jacobs C; Walter C; Ziebart T; Dirks I; Schramm S; Grimm S; Krieger E; Wehrbein H
    Clin Oral Investig; 2015 Apr; 19(3):699-708. PubMed ID: 25055746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate therapy in multiple myeloma: past, present, future.
    Jantunen E
    Eur J Haematol; 2002; 69(5-6):257-64. PubMed ID: 12460229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic effect of bisphosphonates in mice.
    Bonabello A; Galmozzi MR; Bruzzese T; Zara GP
    Pain; 2001 Apr; 91(3):269-275. PubMed ID: 11275384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
    Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS
    Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
    Ural AU; Yilmaz MI; Avcu F; Pekel A; Zerman M; Nevruz O; Sengul A; Yalcin A
    Int J Hematol; 2003 Dec; 78(5):443-9. PubMed ID: 14704038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates: biological response modifiers in breast cancer.
    Paterson AH
    Clin Breast Cancer; 2002 Aug; 3(3):206-16; discussion 217-8. PubMed ID: 12196279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clodronate inhibits adrenocortical cell proliferation and P450c21 activity.
    Fassnacht M; Franke A; Dettling A; Hahner S; Zink M; Wudy S; Allolio B
    J Endocrinol; 2002 Sep; 174(3):509-16. PubMed ID: 12208672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
    Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
    Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2003 Oct; 14(9):767-71. PubMed ID: 14551512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.